How has Agios Pharmaceuticals's other commercial liabilities changed year-over-year?

Agios Pharmaceuticals's other commercial liabilities increased by 26.6% year-over-year, from $20.76M to $26.29M.

What is the long-term trend for Agios Pharmaceuticals's other commercial liabilities?

Over 5 years (2020 to 2025), Agios Pharmaceuticals's other commercial liabilities has grown at a 8.1% compound annual growth rate (CAGR), from $30.8M to $45.46M.

Agios Pharmaceuticals AGIO Other Commercial Liabilities

Other Commercial Liabilities at other companies

Vertex PharmaceuticalsVRTX

——

IncyteINCY

——

Disc MedicineIRON

——

Ultragenyx PharmaceuticalRARE

——

BioCryst PharmaceuticalsBCRX

——

CRISPR TherapeuticsCRSP

——

Other financials

Income statement

See full

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

See full

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

See full

Market cap$2.12B+18.1%

Enterprise value$2.04B+15.2%

P/S32.1×-16.4×

Profitability

See full

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

See full

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agios Pharmaceuticals's other commercial liabilities?: Agios Pharmaceuticals (AGIO) reported other commercial liabilities of $26.29M in Q1 2026.
How has Agios Pharmaceuticals's other commercial liabilities changed year-over-year?: Agios Pharmaceuticals's other commercial liabilities increased by 26.6% year-over-year, from $20.76M to $26.29M.
What is the long-term trend for Agios Pharmaceuticals's other commercial liabilities?: Over 5 years (2020 to 2025), Agios Pharmaceuticals's other commercial liabilities has grown at a 8.1% compound annual growth rate (CAGR), from $30.8M to $45.46M.